A Type I/Type III PKS Hybrid Generates Cinnamomycin A-D

Area of Science:

• Biochemistry
• Molecular Biology
• Natural Product Chemistry

Background:

• 3,5-Dihydroxybenzoic acid (3,5-DHBA) is an unusual starter unit for bacterial type I polyketide synthases (PKS).
• Exploring gene clusters for 3,5-DHBA biosynthesis can reveal novel hybrid PKS systems.

Purpose of the Study:

• To discover and characterize new compounds derived from 3,5-DHBA.
• To investigate the biosynthetic pathway of these novel compounds.

Main Methods:

• Genome mining for 3,5-DHBA-specific gene clusters.
• Genetic manipulation and enzymatic assays.
• Precursor feeding experiments.

Main Results:

• Discovery and characterization of four atypical compounds: cinnamomycin A-D.
• Demonstration of selective antiproliferative activity of cinnamomycins.
• Elucidation of the biosynthetic pathway for cinnamomycins.

Conclusions:

• 3,5-DHBA can serve as a starter unit for bacterial type I PKS, leading to novel compound discovery.
• Cinnamomycins represent a new class of compounds with potential therapeutic applications.
• The proposed biosynthetic pathway provides a foundation for further engineering of PKS systems.